LifeVantage Appoints Kevin McMurray as General Counsel
October 02 2017 - 9:00AM
LifeVantage Corporation (Nasdaq:LFVN) announced today the
appointment of Kevin McMurray to the position of General Counsel.
“We’re thrilled to have Kevin join our management team,” said
LifeVantage President and Chief Executive Officer, Darren Jensen.
“He brings a track record of success, an astute legal mind and a
team-first philosophy to his work. He has deep experience in our
industry, and guided businesses through similar periods of growth
and evolution such as we are undertaking. I can’t think of anyone
better suited to help us navigate our continued expansion.”
A veteran of the health and wellness industry, Mr. McMurray
brings over 25 years of legal expertise to LifeVantage where he
will be responsible for leading the legal department and serving as
counsel to the Board of Directors, Chairman of the Board, and Chief
Executive Officer. Prior to joining LifeVantage, Mr. McMurray
served as Assistant General Counsel at USANA Health Sciences since
2004. While at USANA, he helped implement its first distributor
compliance program while playing an integral role in the company’s
expansion into new international markets.
“Throughout his career, Kevin has demonstrated the well-rounded
ability to understand and navigate a broad range of legal issues,”
said LifeVantage Chief Sales Officer, Justin Rose. “His industry
experience combined with an uncanny ability to create innovative
solutions that create real value is something we look forward
to.”
Mr. McMurray also served as Associate General Counsel for
Unicity International and Assistant General Counsel for Shaklee
Corporation. He received his J.D. from Creighton University and a
Master of Laws Degree from the University of the Pacific.
“I’m very excited about this new opportunity,” said McMurray.
“I’ve always been drawn to the health and wellness industry because
I love the lifestyle it promotes. LifeVantage has proven that it’s
an industry leader with its innovative approach to product research
and development. I look forward to being an active member of the
management team as we grow and expand into new international
markets.”
About LifeVantage Corporation
LifeVantage Corporation is a science-based health, wellness and
anti-aging company dedicated to helping people transform themselves
internally and externally at a cellular level. Their
scientifically-validated product line includes Protandim® Nrf2 and
NRF1 Synergizers, TrueScience® Anti-Aging Skin Care Regimen,
Petandim®, AXIO® Smart Energy and the PhysIQ™ Smart Weight
Management System. LifeVantage (Nasdaq:LFVN) was founded in 2003
and is headquartered in Salt Lake City, Utah. For more information,
visit www.lifevantage.com.
Forward Looking Statements
This document contains forward-looking statements made pursuant
to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. Words and expressions reflecting optimism,
satisfaction or disappointment with current prospects, as well as
words such as "believe," "hopes," "intends," "estimates,"
"expects," "projects," "plans," "anticipates," "look forward to"
and variations thereof, identify forward-looking statements, but
their absence does not mean that a statement is not
forward-looking. Examples of forward-looking statements include,
but are not limited to, statements we make regarding our future
growth, distributor success and shareholder value. Such
forward-looking statements are not guarantees of performance and
the Company's actual results could differ materially from those
contained in such statements. These forward-looking statements are
based on the Company's current expectations and beliefs concerning
future events affecting the Company and involve known and unknown
risks and uncertainties that may cause the Company's actual results
or outcomes to be materially different from those anticipated and
discussed herein. These risks and uncertainties include, among
others, those discussed in greater detail in the Company's Annual
Report on Form 10-K and the Company's Quarterly Report on Form 10-Q
under the caption "Risk Factors," and in other documents filed by
the Company from time to time with the Securities and Exchange
Commission. The Company cautions investors not to place undue
reliance on the forward-looking statements contained in this
document. All forward-looking statements are based on information
currently available to the Company on the date hereof, and the
Company undertakes no obligation to revise or update these
forward-looking statements to reflect events or circumstances after
the date of this document, except as required by law.
Investor Relations Contact:Scott Van Winkle
Managing Director, ICR (617) 956-6736scott.vanwinkle@icrinc.com
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Apr 2023 to Apr 2024